Skip to content
Riskpilot
← Back to search
Sign in
Get full access
LobSor Pharmaceuticals Aktiebolag
AB
Active
Org 5569304768
Kålsängsgränd 10 D, 753 19
Uppsala
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2013
3 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
LobSor Pharmaceuticals Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
25M
49M
74M
99M
38M
2021
12M
2022
86M
2023
11M
2024
13M
2025
EBITDA
SEK millions
0M
22M
44M
66M
87M
57M
2021
36M
2022
76M
2023
18M
2024
18M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
37 569
12 465
86 393
10 549
12 722
Staff expenses
—
—
—
−283
−310
EBITDA
56 960
35 991
76 339
18 160
18 093
Depreciation & amort.
−9 615
−2 112
−2 217
−10 780
−11 423
EBIT
47 345
33 879
74 122
7 380
6 670
Net financials
489
2 798
5 036
−22 248
−16 235
Profit before tax
47 835
21 369
5 045
−14 868
−9 564
Tax
4 169
−4 169
−0
760
507
Net profit
52 004
17 200
5 045
−14 108
−9 057
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
73 860
106 968
186 400
167 289
150 355
Equity
73 102
90 301
95 137
15 248
6 191
Long-term debt
0
0
0
—
—
Short-term debt
759
16 667
91 264
39 015
35 265
Total debt
759
16 667
91 264
39 015
35 265
Financial ratios
5-year trend
EBITDA margin
142.2%
This company
15.8%
Market median
+800% vs market
2021
2025
Equity ratio
4.1%
This company
38.2%
Market median
-89% vs market
2021
2025
Return on equity
-146.3%
This company
18.4%
Market median
-895% vs market
2021
2025
Net profit margin
-71.2%
This company
8.1%
Market median
-979% vs market
2021
2025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2021
2025
Debt / equity
23.29×
This company
0.62×
Market median
-3656% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on LobSor Pharmaceuticals Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
